Uncategorized
Novaliq Announces First Patient Enrolled in Its SEECASE Phase 2 Trial of NOV03 for the Treatment of Dry Eye Disease
HEIDELBERG, Germany--(BUSINESS WIRE)--#CyclASol--Novaliq GmbH has begun randomization of patients in its SEECASE Phase 2 clinical trial of NOV03 for the treatment of dry eye disease (DED).